Recurrent Lower Urinary Tract Infections Have a Detrimental Effect on Patient Quality of Life: a Prospective, Observational Study

Grabe M, Bjerklund-Johansen TE, Botto H, et al. European Association of Urology guidelines on urological infections. 2010. http://www.uroweb.org . Accessed April 1, 2010.

McCue JD. UTIs in at-risk patients: are they ‘complicated’? Infect Med. 1999;16:533–40.

Foxman B, Brown P. Epidemiology of urinary tract infections: transmission and risk factors, incidence, and costs. Infect Dis Clin North Am. 2003;17:227–41.

Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med. 2002;113:5S–13S.

Guay DR. Contemporary management of uncomplicated urinary tract infections. Drugs. 2008;68:1169–205.

Gupta K, Hooton TM, Naber KG, et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis. 2011;52:e103–20.

Grabe M, Bjerklund-Johansen TE, Botto H, et al. European Association of Urology guidelines on urological infections 2014 (limited update of 2013). http://www.uroweb.org . Accessed April 1, 2014.

Mulvey MA, Schilling JD, Hultgren SJ. Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection. Infect Immun. 2001;69:4572–9.

Epp A, Larochelle A, Lovatsis D, et al. Recurrent urinary tract infection. J Obstet Gynaecol Can. 2010;32:1082–101.

Chiavaroli C, Moore A. An hypothesis to link the opposing immunological effects induced by bacterial lysate OM-89 in urinary tract infection and rheumatoid arthritis. Biodrugs. 2006;20:141–9.

Schulman CC, Corbusier A, Michiels H, Taenzer HJ. Oral immunotherapy of recurrent urinary tract infections: a double-blind placebo-controlled multicenter study. J Urol. 1993;150:917–21.

Magasi P, Panovics J, Illes A, Nagy M. Uro-Vaxom and the management of recurrent urinary tract infection in adults: a randomized multicenter double-blind trial. Eur Urol. 1994;26:137–40.

Bauer HW, Alloussi S, Egger G, Blümlein HM, Cozma G, Schulman CC. A long-term, multicenter, double-blind study of an Escherichia coli extract (OM-89) in female patients with recurrent urinary tract infections. Eur Urol. 2005;47:542–8.

Bauer HW, Rahlfs VW, Lauener PA, Blessmann GS. Prevention of recurrent urinary tract infections with immuno-active E. coli fractions: a meta-analysis of five placebo-controlled double-blind studies. Int J Antimicrob Agents. 2002;19:451–6.

Naber KG, Cho YH, Matsumoto T, Schaeffer AJ. Immunoactive prophylaxis of recurrent urinary tract infections: a meta-analysis. Int J Antimicrob Agents. 2009;33:111–9.

Reid G, Bruce AW. Urogenital infections in women: can probiotics help? Postgrad Med J. 2003;79:428–32.

Lowe NK, Ryan-Wenger NA. Military women’s risk factors for and symptoms of genitourinary infections during deployment. Mil Med. 2003;168:569–74.

Ellis AK, Verma S. Quality of life in women with urinary tract infections: is benign disease a misnomer? J Am Board Fam Pract. 2000;13:392–7.

De Moura JL. Urinary infection in the adult. Acta Med Port. 1999;12:57–62.

Schleupner CJ. Urinary tract infections. Postgrad Med. 1997;101:231–7.

Bula CJ, Ghilardi G, Wietlisbach V, Petignat C, Francioli P. Infections and functional impairment in nursing home residents: a reciprocal relationship. J Am Geriatr Soc. 2004;52:700–6.

Van Oyen H, Van Oyen P. Urinary incontinence in Belgium; prevalence, correlates and psychosocial consequences. Acta Clin Belg. 2002;57:207–18.

Gonder MJ. Urologic considerations in the elderly. Prim Care. 1982;9:71–5.

Woo BK, Daly JW, Allen EC, Jeste DV, Sewell DD. Unrecognized medical disorders in older psychiatric inpatients in a senior behavioral health unit in a university hospital. J Geriatr Psychiatry Neurol. 2003;16:121–5.

Ernst EJ, Ernst ME, Hoehns JD, Bergus GR. Women’s quality of life is decreased by acute cystitis and antibiotic adverse effects associated with treatment. Health Qual Life Outcomes. 2005;3:45.

Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361–70.

Shaw C, Matthews RJ, Perry SI, et al. Validity and reliability of a questionnaire to measure the impact of lower urinary tract symptoms on quality of life: the Leicester Impact Scale. Neurourol Urodyn. 2004;23:229–36.

Carr AJ, Gibson B, Robinson PG. Measuring quality of life: Is quality of life determined by expectations or experience? BMJ. 2001;322:1240–3.

Platt FW, Keating KN. Differences in physician and patient perceptions of uncomplicated UTI symptom severity: understanding the communication gap. Int J Clin Pract. 2007;61:303–8.

Bermingham SL, Ashe JF. Systematic review of the impact of urinary tract infections on health-related quality of life. BJU Int. 2012;110:E830–6.